Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 1.

Table. 1.

Distribution of demographic and clinical characteristics according to time to treatment (n = 91)

Variable Early (E) (n = 22; 24.2%) Intermediate (I) (n = 48; 52.7%) Late (L) (n = 21; 23.1%) Total (n = 91) p-value
Age (yr)a) 56.5 (32–75) 53 (30–77) 50 (31–76) 53 (30–77) 0.154
Sex (female) 13 (59.1) 37 (77.1) 17 (80.9) 67 (73.6) 0.22
Preoperative clinical diagnosis
Symptomatic gallstone disease 16 (72.7) 33 (68.8) 12 (57.1) 61 (67.0) 0.516
Asymptomatic gallstone disease 2 (9.1) 3 (6.3) 0 (0) 5 (5.5) 0.865
Acute calculous cholecystitis 1 (4.5) 8 (16.7) 6 (28.6) 15 (16.5) 0.112
Complicated gallstone diseaseb) 3 (13.6) 4 (8.3) 3 (14.3) 10 (11.0) 0.739
Cholecystectomy
Laparoscopic 13 (59.1) 29 (60.4) 11 (52.4) 53 (58.2) 0.818
Open 7 (31.8) 18 (37.5) 9 (42.9) 34 (37.3) 0.755
Laparoscopic → Open 2 (9.1) 1 (2.1) 1 (4.8) 4 (4.5) 0.341
Presentation
Positive biopsy (no symptoms) 13 (59.1) 37 (77.1) 11 (52.4) 61 (67.0) 0.088
Pain abdomen 7 (31.8) 7 (14.6) 8 (38.1) 33 (36.2) 0.001*
Jaundice 1 (4.5) 1 (2.1) 2 (9.5) 4 (4.4) 0.253
Weight loss 4 (18.2) 10 (20.8) 9 (42.9) 23 (25.2) 0.139

Values are presented as frequency (%). Compared by chi-square test or Fisher exact test (*p < 0.05 significant).

a)Median (range), compared by Kruskal–Wallis H test. b)Past history of cholecystitis/resolved pancreatitis.

Ann Hepatobiliary Pancreat Surg 2021;25:492-9 https://doi.org/10.14701/ahbps.2021.25.4.492
© 2021 Ann Hepatobiliary Pancreat Surg